Inventor · disambiguated record
Ann Marie Leen
Also filed as: LEEN ANN · LEEN ANN M · LEEN ANN MARIE
21 granted patents·24 pending applications·497 citations·filing 2010–2024
95Inventor score
Top patents by PatentIndex Score
45 records- 0198US10533156B2Methods of cell culture for adoptive cell therapyWILSON WOLF MFG·Filed 2016·Granted Jan 14, 2020·30 cites·20 claims
- 0298US8956860B2Methods of cell culture for adoptive cell therapyVERA JUAN F·Filed 2012·Granted Feb 17, 2015·197 cites·21 claims
- 0398US8809050B2Methods of cell culture for adoptive cell therapyVERA JUAN F·Filed 2010·Granted Aug 19, 2014·173 cites·14 claims
- 0497US11999969B2Methods of cell culture for adoptive cell therapyWILSON WOLF MFG·Filed 2023·Granted Jun 4, 2024·2 cites·20 claims
- 0596US9567565B2Methods of cell culture for adoptive cell therapyVERA JUAN F·Filed 2014·Granted Feb 14, 2017·33 cites·23 claims
- 0694US11268066B2Methods of cell culture for adoptive cell therapyWILSON WOLF MFG·Filed 2019·Granted Mar 8, 2022·3 cites·24 claims
- 0793US11118164B2Pepmixes to generate multiviral CTLs with broad specificityBAYLOR COLLEGE MEDICINE·Filed 2018·Granted Sep 14, 2021·7 cites·14 claims
- 0892US12454667B2Methods of cell culture for adoptive cell therapyWILSON WOLF MFG·Filed 2024·Granted Oct 28, 2025·0 cites·12 claims
- 0991US10385316B2Generation of CTL lines with specificity against multiple tumor antigens or multiple virusesBAYLOR COLLEGE MEDICINE·Filed 2016·Granted Aug 20, 2019·8 cites·15 claims
- 1090US11717538B2Reversing the effects of the tumor microenvironment using chimeric cytokine receptorsBAYLOR COLLEGE MEDICINE·Filed 2020·Granted Aug 8, 2023·2 cites·4 claims
- 1189US9963677B2Generation of CTL lines with specificity against multiple tumor antigens or multiple virusesLEEN ANN M·Filed 2010·Granted May 8, 2018·14 cites·28 claims
- 1286US11167024B2Immunogenic antigen identification from a pathogen and correlation to clinical efficacyBAYLOR COLLEGE MEDICINE·Filed 2016·Granted Nov 9, 2021·5 cites·9 claims
- 1386US10351824B2Process of expanding T cellsROONEY CLIONA M·Filed 2012·Granted Jul 16, 2019·12 cites·44 claims
- 1486US2024408200A1Methods of cell culture for adoptive cell therapyWILSON WOLF MFG·Filed 2024·Application pending·0 cites
- 1585US2023357721A1Generation of ctl lines with specificity against multiple tumor antigens or multiple virusesBAYLOR COLLEGE MEDICINE·Filed 2023·Application pending·0 cites
- 1684US11821002B2Methods of cell culture for adoptive cell therapyWILSON WOLF MFG·Filed 2022·Granted Nov 21, 2023·0 cites·18 claims
- 1783US10548921B2Reversing the effects of the tumor microenvironment using chimeric cytokine receptorsLEEN ANN MARIE·Filed 2012·Granted Feb 4, 2020·9 cites·6 claims
- 1883US2024002797A1Methods of cell culture for adoptive cell therapyWILSON WOLF MFG·Filed 2023·Application pending·0 cites
- 1983US2023114971A1Generation of ctl lines with specificity against multiple tumor antigens or multiple virusesBAYLOR COLLEGE MEDICINE·Filed 2022·Application pending·0 cites
- 2083US2023383250A1Methods of cell culture for adoptive cell therapyWILSON WOLF MFG·Filed 2023·Application pending·0 cites
- 2182US12435309B2Generation of CTL lines with specificity against multiple tumor antigens or multiple virusesBAYLOR COLLEGE MEDICINE·Filed 2022·Granted Oct 7, 2025·0 cites·8 claims
- 2280US11981923B2Pepmixes to generate multiviral CTLS with broad specificityBAYLOR COLLEGE MEDICINE·Filed 2022·Granted May 14, 2024·0 cites·11 claims
- 2377US12227764B2Pepmixes to generate multiviral CTLs with broad specificityBAYLOR COLLEGE MEDICINE·Filed 2021·Granted Feb 18, 2025·0 cites·21 claims
- 2477US2025009870A1Immunogenic antigen identification from a pathogen and correlation to clinical efficacyBAYLOR COLLEGE MEDICINE·Filed 2024·Application pending·0 cites
- 2574US10584158B2Immunosuppressive TGF-β signal converterBAYLOR COLLEGE MEDICINE·Filed 2014·Granted Mar 10, 2020·2 cites·3 claims
- 2674US2022152111A1Process for t cell expansionALLOVIR INC·Filed 2022·Application pending·0 cites
- 2771US11931408B2Immunogenic antigen identification from a pathogen and correlation to clinical efficacyBAYLOR COLLEGE MEDICINE·Filed 2021·Granted Mar 19, 2024·0 cites·6 claims
- 2867US2019264176A1Generation of ctl lines with specificity against multiple tumor antigens or multiple virusesBAYLOR COLLEGE MEDICINE·Filed 2019·Application pending·0 cites
- 2966US2019144826A1Generation of ctl lines with specificity against multiple tumor antigens or multiple virusesBAYLOR COLLEGE MEDICINE·Filed 2019·Application pending·0 cites
- 3065US11963979B2Process for T cell expansionALLOVIR INC·Filed 2018·Granted Apr 23, 2024·0 cites·28 claims
- 3165US2024325447A1Generation of t cell lines with specificity against one or more neoantigensBAYLOR COLLEGE MEDICINE·Filed 2022·Application pending·0 cites
- 3264US2025325668A1Targeting common somatic mutations in breast cancer with neo-antigen specific adoptive t cell therapyBAYLOR COLLEGE MEDICINE·Filed 2022·Application pending·0 cites
- 3364US2016208216A1Methods of cell culture for adoptive cell therapyVERA JUAN F·Filed 2016·Application pending·0 cites
- 3462US2015010519A1Pepmixes to generate multiviral ctls with broad specificityBAYLOR COLLEGE MEDICINE·Filed 2013·Application pending·0 cites
- 3561US2025032617A1Transgenic t cell receptors targeting neoantigens for diagnosis, prevention, and/or treatment of hematological cancersBAYLOR COLLEGE MEDICINE·Filed 2022·Application pending·0 cites
- 3660US2024335537A1Engineered soluble decoy receptors to enhance cancer immunotherapyBAYLOR COLLEGE MEDICINE·Filed 2022·Application pending·0 cites
- 3758US2020140520A1Immunosuppressive tgf-b signal converterBAYLOR COLLEGE MEDICINE·Filed 2020·Application pending·0 cites
- 3855US2023293580A1Sars-cov2-specific t cell compositions and their use in treating and preventing coronavirus and other respiratory virus infectionsBAYLOR COLLEGE MEDICINE·Filed 2021·Application pending·0 cites
- 3955US2023210901A1Overcoming the tumor microenvironment for cell therapy by targeting myeloid derived suppressor cells through a trail-r2 specific receptorBAYLOR COLLEGE MEDICINE·Filed 2021·Application pending·0 cites
- 4053US2023295565A1Universal antigen-specific t cell banks and methods of making and using the same therapeuticallyBAYLOR COLLEGE MEDICINE·Filed 2021·Application pending·0 cites
- 4152US2023028788A1T cell performance assay as a prognostic factor for clinical outcomeBAYLOR COLLEGE MEDICINE·Filed 2020·Application pending·0 cites
- 4252US2022288119A1Third party virus-specific t cell compositions, and methods of making and using the same in anti-viral prophylaxisBAYLOR COLLEGE MEDICINE·Filed 2020·Application pending·0 cites
- 4350US2022169986A1Multi-respiratory virus antigen-specific t cells and methods of making and using the same therapeuticallyBAYLOR COLLEGE MEDICINE·Filed 2020·Application pending·0 cites
- 4446US2022257654A1Antigen-specific t cell banks and methods of making and using the same therapeuticallyBAYLOR COLLEGE MEDICINE·Filed 2020·Application pending·0 cites
- 4529US2017246278A1Bipartite and tripartite signaling immune cellsBAYLOR COLLEGE MEDICINE·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ann Marie Leen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →